Business Description
Chemed Corp
NAICS : 621610
SIC : 8082
ISIN : US16359R1032
Share Class Description:
CHE: Ordinary SharesTotal Employee Number:
15,811Compare
Compare
Traded in other countries / regions
CHE.USACXM.GermanyCHE.Mexico Index Membership
Russell 1000Russell 3000 IPO Date
1972-06-01Description
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | 0.67 | |||||
Interest Coverage | 107.38 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.73 | |||||
Beneish M-Score | -3.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 3.9 | |||||
3-Year EPS without NRI Growth Rate | 4.7 | |||||
3-Year FCF Growth Rate | 10.4 | |||||
3-Year Book Growth Rate | 10 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.52 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.62 | |||||
9-Day RSI | 54.15 | |||||
14-Day RSI | 58.63 | |||||
3-1 Month Momentum % | 16.32 | |||||
6-1 Month Momentum % | 8.05 | |||||
12-1 Month Momentum % | 12.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.91 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 1.67 | |||||
Days Sales Outstanding | 27.77 | |||||
Days Payable | 13.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.47 | |||||
Dividend Payout Ratio | 0.11 | |||||
3-Year Dividend Growth Rate | 14.1 | |||||
Forward Dividend Yield % | 0.51 | |||||
5-Year Yield-on-Cost % | 0.76 | |||||
3-Year Average Share Buyback Ratio | 2.7 | |||||
Shareholder Yield % | 8.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 33.11 | |||||
Operating Margin % | 13.57 | |||||
Net Margin % | 10.6 | |||||
EBITDA Margin % | 16.91 | |||||
FCF Margin % | 12.47 | |||||
OCF Margin % | 15.03 | |||||
ROE % | 27.87 | |||||
ROA % | 17.2 | |||||
ROIC % | 18.6 | |||||
3-Year ROIIC % | -24.84 | |||||
ROC (Joel Greenblatt) % | 107.49 | |||||
ROCE % | 28.6 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 26.86 | |||||
Forward PE Ratio | 20.96 | |||||
PE Ratio without NRI | 24.06 | |||||
Shiller PE Ratio | 29.6 | |||||
Price-to-Owner-Earnings | 23.84 | |||||
PEG Ratio | 10.03 | |||||
PS Ratio | 2.83 | |||||
PB Ratio | 8.42 | |||||
Price-to-Tangible-Book | 133.05 | |||||
Price-to-Free-Cash-Flow | 22.88 | |||||
Price-to-Operating-Cash-Flow | 18.97 | |||||
EV-to-EBIT | 19.45 | |||||
EV-to-Forward-EBIT | 15.98 | |||||
EV-to-EBITDA | 16.51 | |||||
EV-to-Forward-EBITDA | 14.64 | |||||
EV-to-Revenue | 2.79 | |||||
EV-to-Forward-Revenue | 2.67 | |||||
EV-to-FCF | 22.39 | |||||
Price-to-GF-Value | 0.79 | |||||
Price-to-Projected-FCF | 1.73 | |||||
Price-to-DCF (Earnings Based) | 1.17 | |||||
Price-to-DCF (FCF Based) | 1.04 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Graham-Number | 11.93 | |||||
Earnings Yield (Greenblatt) % | 5.14 | |||||
FCF Yield % | 4.63 | |||||
Forward Rate of Return (Yacktman) % | 7.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CHE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chemed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,595.001 | ||
| EPS (TTM) ($) | 19.91 | ||
| Beta | 0.3076 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 25.71 | ||
| 14-Day RSI | 58.63 | ||
| 14-Day ATR ($) | 13.24398 | ||
| 20-Day SMA ($) | 534.7955 | ||
| 12-1 Month Momentum % | 12.75 | ||
| 52-Week Range ($) | 365.205 - 557 | ||
| Shares Outstanding (Mil) | 13.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chemed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chemed Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 10:00 | In 70 days | ||
| Third quarter earnings results for 2026 | 2026-10-28 | In 68 days | ||
| USD 0.700000 Cash Dividend | 2026-08-17 | 532.88 (-0.45%) | ||
| Second quarter earnings conference call for 2026 | 2026-07-29 10:00 | 517.63 (+0.30%) | ||
| Second quarter earnings results for 2026 | 2026-07-28 | 509.34 (-0.27%) | ||
| USD 0.600000 Cash Dividend | 2026-05-28 | 439.41 (+0.39%) | ||
| RBC Capital Markets Global Healthcare Conference | 2026-05-20 08:30 | 440.05 (-1.18%) | ||
| General meeting for 2026 | 2026-05-18 11:00 | 434.53 (+1.40%) | ||
| Guidance call for 2026 | 2026-05-12 15:00 | 421.43 (-0.88%) | ||
| First quarter earnings conference call for 2026 | 2026-04-24 10:00 | 382.97 (+2.36%) |
Show
Entries
Chemed Corp Frequently Asked Questions
What is Chemed Corp(CHE)'s stock price today?
The current price of CHE is $534.88. The 52 week high of CHE is $557.00 and 52 week low is $365.21.
When is next earnings date of Chemed Corp(CHE)?
The next earnings date of Chemed Corp(CHE) is 2026-10-28 Est..
Does Chemed Corp(CHE) pay dividends? If so, how much?
The Dividend Yield %  of Chemed Corp(CHE) is 0.47% (As of Today), Highest Dividend Payout Ratio of Chemed Corp(CHE) was 0.14. The lowest was 0.07. And the median was 0.08. The  Forward Dividend Yield % of Chemed Corp(CHE) is 0.51%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers